Observational analysis shows dialysis reduces health-related quality of life in CKD patients, indicating a need for targeted interventions.
Background: There is sparse data about the change in HRQoL with the temporal progression of CKD. In this study, we assessed the association between change in CKD stages, overall and domain-specific QoL and determined the factors that were associated with this change. Methods: Data was sourced from a multi-centre study that included 1,290 adult patients aged 18 years and over across 6 centres in Australia. EQ-5D-3L was collected at baseline, 2 and 4 years. Changes in CKD stages were treated as a time-varying exposure; generalized estimating equations were used to model the changes in HRQoL. Results: With reference to patients with CKD (G3-5), patients treated with dialysis had a reduction of 0.06 (-0.09 to -0.04) in overall HRQoL scores over the 4-years and experienced higher odds of reporting lower HRQoL across all domains: mobility (1.91 [1.53 – 2.38]), self-care (2.30 [1.67 – 3.16]), usual activity (2.70 [ 2.18 – 3.38]), pain (1.19 [ 0.97 – 1.46]) and anxiety (1.40 [1.12 – 1.75]). Transplant recipients showed no significant decline in overall HRQoL (p = 0.13) but had increased odds of reduced mobility (1.74 [ 1.40 – 2.18]) and usual activity (1.35 [1.07 – 1.71]). Female sex, smoking, prevalent diabetes mellitus, lower educational attainment and Middle Eastern ethnicity were associated with lower HRQoL. Conclusions: Patients on maintenance dialysis, but not transplant recipients, experienced a significant decline in overall HRQoL (0.06) over the 4 years compared to patients with CKD (G3-5). These utility-based HRQOL estimates are essential for future economic evaluations in kidney trials.
No takes yet. Share an insight, caveat, or question.
Kieu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: